IDEXX LABORATORIES INC /DE Operating Leases, Future Minimum Payments, Due in Five Years
IDEXX LABORATORIES INC /DE (IDXX) had Operating Leases, Future Minimum Payments, Due in Five Years of $8.50 million as of 2018-12-31, per its 10-K filed 2020-02-14.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears · last filed 2020-02-14
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $8.50M; Operating Leases, Future Minimum Payments, Due in Five Years as first filed $8.52M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $7.14M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $5.96M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $5.61M.
| Period end | Operating Leases, Future Minimum Payments, Due in Five Years | Operating Leases, Future Minimum Payments, Due in Five Years as first filed |
|---|---|---|
| 2018-12-31 | $8.50M 10-K · filed 2020-02-14 | $8.52M 10-K · filed 2019-02-15 |
| 2017-12-31 | $7.14M 10-K · filed 2018-02-16 | |
| 2016-12-31 | $5.96M 10-K · filed 2017-02-17 | |
| 2015-12-31 | $5.61M 10-K · filed 2016-02-17 | |
| 2014-12-31 | $6.73M 10-K · filed 2015-02-17 | |
| 2013-12-31 | $7.98M 10-K · filed 2014-02-18 | |
| 2012-12-31 | $7.32M 10-K · filed 2013-02-19 | |
| 2011-12-31 | $5.15M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |